
| Serial Number | 88369612 |
| Word Mark | KALEIDO |
| Filing Date | Wednesday, April 3, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 23, 2021 |
| Registration Number | 6301922 |
| Registration Date | Tuesday, March 23, 2021 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 12, 2019 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Preparations and substances for pharmaceutical and medical purposes, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, psychiatric conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, cardiovascular diseases, nephrologic diseases and conditions, including organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, including growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis; therapeutic pharmaceuticals for medical use, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, psychiatric conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, cardiovascular diseases, nephrologic diseases and conditions, including organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, including growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis |
| Description of Mark | The mark consists of the word "KALEIDO" to the right of the stylized representation of a round kaleidoscope image. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 22, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, February 19, 2019 |
| First Use In Commerce Date | Wednesday, July 8, 2020 |
| Party Name | Kaleido Biosciences, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Lexington, MA 02421 US |
| Party Name | Kaleido Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Lexington, MA 02421 US |
| Party Name | Kaleido Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Lexington, MA 02421 US |
| Event Date | Event Description |
| Saturday, April 6, 2019 | NEW APPLICATION ENTERED |
| Monday, April 22, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, April 23, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, June 13, 2019 | ASSIGNED TO EXAMINER |
| Friday, June 14, 2019 | NON-FINAL ACTION WRITTEN |
| Friday, June 14, 2019 | NON-FINAL ACTION E-MAILED |
| Friday, June 14, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, October 2, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, October 2, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, October 2, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, October 2, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, October 4, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, October 5, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, October 10, 2019 | ASSIGNED TO LIE |
| Wednesday, October 23, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 12, 2019 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 12, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 7, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 7, 2020 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, July 7, 2020 | SOU EXTENSION 1 FILED |
| Tuesday, July 7, 2020 | SOU EXTENSION 1 GRANTED |
| Thursday, July 9, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, January 7, 2021 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, January 27, 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, January 7, 2021 | USE AMENDMENT FILED |
| Thursday, February 4, 2021 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, February 15, 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, February 16, 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, March 23, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Monday, March 23, 2026 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |